November 6, 2015 — The Medicare Payment Advisory Commission discussed options to reduce Medicare Part B drug payments to hospitals participating in the 340B program during its November public meeting, held yesterday. MedPAC previously raised this issue in its June 2015 report to Congress but made no recommendations.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)